Buy & Sell Eli Lilly And Co (LLY) – Eli Lilly And Co Price Today
Aura AI Summary
Key Stats
- $1.01TMarket Cap
- HealthSector
- -10.92%3M Drawdown
- $1.05TEnterprise Value
- 0.61%Dividend Yield
- 98% Buy | 2% SellTrading Activity
- 89 daysTypical Hold Time
Eli Lilly And Co (LLY) is currently valued at a market capitalization of $1.01T, with an enterprise value of $1.05T. Over the past 52 weeks, Eli Lilly And Co has traded between a low of $625.65 and a high of $1,160.95, highlighting its annual price range. Over the past three months, Eli Lilly And Co has recorded a drawdown of -10.92%, reflecting recent price volatility. Eli Lilly And Co offers a dividend yield of 0.61%, with the most recent dividend of $1.73 paid on 15 May 26. On average, investors hold Eli Lilly And Co for approximately 89 days, indicating typical investor behavior on the platform.
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Most Recent News
Defiance ETFs launches SPCQ, a 2x inverse leveraged ETF targeting daily SpaceX stock declines.
Defiance ETFs introduced the Defiance Daily Target 2X Short SpaceX ETF (SPCQ), designed to provide investors with double inverse exposure to SpaceX's daily stock price movements. This ETF aims to deliver -200% of SpaceX's daily returns, allowing inve...

Halper Sadeh LLC probes fairness of recent major company sales and mergers for shareholders.
Halper Sadeh LLC, an investor rights law firm, is investigating whether shareholders of Open Lending Corporation, Nuvalent, Organon & Co., and SUNation Energy are receiving fair deals in their companies' recent sales or mergers. The firm suggests ins...

Global GLP-1 receptor agonist market to reach $95.3B by 2035, growing at 12.1% CAGR driven by diabetes and obesity demand.
The global GLP-1 receptor agonist market, used primarily for type 2 diabetes and obesity management, is projected to grow from $28.7 billion in 2025 to $95.3 billion by 2035, at a compound annual growth rate of 12.1%. Growth is fueled by rising diabe...
